Companies → Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Save to list
Remove

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

China, Tianjin
Description
by AI
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is a professional and commercial equipment and supplies merchant wholesaler, pharmaceutical and medicine manufacturer, and drugs and druggists' sundries merchant wholesaler. The company is located at No. 17, Paidi Road, Nankai District, Tianjin, China.
Address:

No.17

Baidi Road

Nankai District Tianjin

Tianjin

300000 China

Revenue
SGX - Delayed Quote - USD
T14.SI
Candle
Line
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/22/2026
Market Cap: 4.15 B
Enterprise Value: 4.00 B
Trailing P/E: 4.82
Forward P/E: 12.31
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 3.21
Price/Book (mrq): 1.92
Enterprise Value/Revenue: 5.13
Enterprise Value/EBITDA: 6.56
Financial Highlights
Profitability and Income Statement
Profit Margin: 66.68%
Return on Assets (ttm): 4.92%
Return on Equity (ttm): 46.11%
Revenue (ttm): 5.37 B
Net Income Avi to Common (ttm): 3.58 B
Diluted EPS (ttm): 0.68
Balance Sheet and Cash Flow
Total Cash (mrq): 1.73 B
Total Debt/Equity (mrq): 0.23%
Levered Free Cash Flow (ttm): 296.22 M
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.